Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
700.65B
Market cap700.65B
Price-Earnings ratio
48.75
Price-Earnings ratio48.75
Dividend yield
0.79%
Dividend yield0.79%
Average volume
3.70M
Average volume3.70M
High today
$737.83
High today$737.83
Low today
$729.04
Low today$729.04
Open price
$733.50
Open price$733.50
Volume
2.22M
Volume2.22M
52 Week high
$954.00
52 Week high$954.00
52 Week low
$623.78
52 Week low$623.78

LLY News

Seeking Alpha 13h
Defiance ETFs launches 2X short ETF on Eli Lilly

Healthcare Defiance ETFs launches 2X short ETF on Eli Lilly Sep. 03, 2025 1:02 PM ET Eli Lilly and Company (LLY) Stock By: Soumendra Mukherjee, SA News Editor 5...

Defiance ETFs launches 2X short ETF on Eli Lilly
TipRanks 14h
Eli Lilly’s New Obesity Drug Study: Key Insights for Investors

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

Benzinga 14h
After Copycat Boom, China's Drugmakers Target Global Generics

China-based drugmakers that once fueled a surge of copycat weight-loss treatments in the U.S. are now pivoting to generics of Novo Nordisk‘s NVO Wegovy and Eli...

After Copycat Boom, China's Drugmakers Target Global Generics

Analyst ratings

79%

of 29 ratings
Buy
79.3%
Hold
20.7%
Sell
0%

More LLY News

TipRanks 1d
Confidence in Tectonic Therapeutic’s Strategic Approach Amid Eli Lilly’s Trial Setback

Danielle Brill, an analyst from Truist Financial, maintained the Buy rating on Tectonic Therapeutic. The associated price target is $64.00. Elevate Your Investi...

TipRanks 1d
Eli Lilly’s relaxin study stopped early over low probability of benefit

According to a report from Nature Medicine over the weekend, a study of Eli Lilly’s (LLY) relaxin, a peptide hormone that may decrease circulatory congestion an...

TipRanks 2d
Analyst Forecasts $25 Billion of Annual Sales for Eli Lilly’s New Weight-Loss Pill

Wall Street investment firm Jefferies Financial Group (JEF) is forecasting more than $10 billion in annual sales from Eli Lilly’s (LLY) new weight-loss pill tha...

Benzinga 2d
Novo Nordisk's Wegovy Outshines Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke And Death

Novo Nordisk A/S NVO on Sunday presented data from the STEER real-world study of evidence gathered from actual patient experiences at the European Society of Ca...

Novo Nordisk's Wegovy Outshines Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke And Death
TipRanks 2d
Novo Nordisk Stock Jumps and Eli Lilly Falls on Positive Wegovy Data

Shares of Novo Nordisk (NVO) are up 1.6% in pre-market trading after the Danish drugmaker announced that its Wegovy weight-loss drug reduces the risk of heart a...

TipRanks 2d
Eli Lilly & Co: Strong Buy Rating Driven by Promising Weight Loss Drug and Innovative Subscription Model

Geoff Meacham, an analyst from Citi, maintained the Buy rating on Eli Lilly & Co. The associated price target remains the same with $1,190.00. Elevate Your Inve...

TipRanks 3d
Eli Lilly Partners with JD.com to Sell Weight-Loss Drugs in China

Pharmaceutical company Eli Lilly (LLY) is partnering with technology giant JD.com (JD) to market and sell weight-loss drugs in China. Elevate Your Investing Str...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.